AFL
Aflac IncorporatedNYSEFinancial ServicesAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
15.65
PEG
—
P/B
1.99
P/S
3.29
EV/EBITDA
10.72
DCF Value
$171.05
FCF Yield
4.5%
Div Yield
2.1%
Margins & Returns
Gross Margin
38.7%
Operating Margin
26.3%
Net Margin
21.0%
ROE
13.1%
ROA
3.4%
ROIC
3.2%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $4.90B | $1.38B | $2.59 |
| FY 2025 | $17.44B | $3.65B | $6.83 |
| Q3 2025 | $4.79B | $1.64B | $3.08 |
| Q2 2025 | $4.22B | $599.0M | $1.11 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Financial Services
Industry
—
Country
US
Exchange
NYSE
Beta
0.65
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.